RHEOMETRIC SCIENTIFIC INC
10-Q, 1998-10-07
MEASURING & CONTROLLING DEVICES, NEC
Previous: RHEOMETRIC SCIENTIFIC INC, 10-Q, 1998-10-07
Next: RHEOMETRIC SCIENTIFIC INC, DEF 14A, 1998-10-07




                          FORM 10-Q
                              
                        UNITED STATES
             SECURITIES AND EXCHANGE COMMISSION
                   Washington, D.C.  20549
(Mark One)

[ X] QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE
     SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: June 30, 1998
                              ____________
                              
                             OR
                              
[  ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
       OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from           to

Commission file number:  0-14617
                              
                 RHEOMETRIC SCIENTIFIC, INC.
       ______________________________________________
   (Exact name of registrant as specified in its charter)
                              
          New Jersey                         61-0708419
     __________________________    ________________________
 (State or other jurisdiction of    (I.R.S. Employer Identi-
     incorporation or organization)      fication Number)

   One Possumtown Road, Piscataway, NJ           08854-2103
  (Address of principal executive offices)      (Zip Code)
                              
                       (732) 560-8550
       _______________________________________________
    (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                       Yes   X      No
                           _____      _____

Indicate the number of shares outstanding of each of the
issuer's classes of common stock, as of the latest practicable
date.

      Class                       Outstanding at August 1, 1998
________________________        _______________________________
Common Stock, no par value                   13,161,739
                              
                              
<PAGE>

<TABLE>
                              
           RHEOMETRIC SCIENTIFIC, INC. AND SUBSIDIARIES
            CONDENSED CONSOLIDATED BALANCE SHEETS
                              
 (In thousands)            (Unaudited)

<CAPTION>
                                             June        December
                                            30, 1998     31, 1997
                                            __________   __________
<S>                                          <C>       <C>
ASSETS
Current Assets
 Cash                                         $  831     $   297
 Accounts receivable, net                     11,054      14,916
 Inventories, net
  Finished goods                               4,248       5,659
  Work in process                              1,715       2,650
  Assembled components, materials, and parts   6,018       3,550
                                              ______      ______
                                              11,981      11,859
 Prepaid expenses and other assets               872         813
                                              ______      ______
  Total current assets                        24,738      27,885
                                              ______      ______
Property, plant, and equipment                15,974      15,904
 Less accumulated depreciation and
  Amortization                                 9,815       9,475
                                              ______      ______
 Property, plant, and equipment, net           6,159       6,429
Other assets                                   1,011       1,120
                                              ______      ______
  Total Assets                               $31,908     $35,434
                                             =======     =======

LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
 Short-term bank borrowings                  $ 7,313     $ 8,769
 Current maturities of long-term debt            229         227
 Accounts payable                              2,310       3,931
 Borrowings against accounts receivable        1,693         958
Payable to affiliate                           1,478       1,064
Accrued liabilities                            4,123       5,360
                                              ______      ______
  Total current liabilities                   17,146      20,309
                                              ______      ______

Long-term note payable                            37          79
Long-term debt lease obligation                4,738       4,718
Long-term debt - affiliate                     6,258       6,258
Other long-term liabilities                    1,287       1,240
                                              ______      ______

  Total liabilities                           29,466      32,604
                                              ______      ______
Commitments and Contingencies

Shareholders' Equity
 Common stock, stated value of $.001,
  authorized 20,000 shares; issued and
  outstanding 13,162 shares                       13          13
 Additional paid-in capital                   25,517      25,492
 Accumulated deficit                         (22,871)    (22,547)
 Cumulative translation adjustment              (217)       (128)
                                              ______      ______
  Total shareholders' equity                   2,442       2,830
                                              ______      ______

   Total Liabilities & Shareholders' Equity  $31,908     $35,434
                                              ======      ======

See Notes to Condensed Consolidated Financial Statements.
                              
                           2 of 14

<PAGE>

        RHEOMETRIC SCIENTIFIC, INC. AND SUBSIDIARIES
       CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
            (In thousands, except per share data)
                         (Unaudited)
<CAPTION>
                                    Three Months Ended  Six Months Ended
                                          June 30,          June 30,
                                      1998     1997      1998      1997
                                     _______  _______   _______   _______

<S>                                  <C>      <C>      <C>      <C>
Sales                                $ 8,703  $10,391  $15,497   $18,708

Cost of sales                          4,478    5,319    7,997    10,078
                                      ______   ______   ______    ______
Gross profit                           4,225    5,072    7,500     8,630
                                      ______   ______   ______    ______
General and administrative expenses      384      854      670     1,559

Marketing and selling expenses         2,261    2,364    4,600     4,543

Research and development expenses        575      730    1,094     1,477

Goodwill and intangible amortization      62       54      121       134

Total Operating Expenses               3,282    4,002    6,485     7,713
                                      ______   ______   ______    ______

Operating income                         943    1,070    1,015       917

Interest expense                        (383)    (351)    (765)     (762)
  Interest expense - Affiliate          (222)    (207)    (436)     (410)
  Interest income                         --        3       --        20
  Foreign currency (loss)/gain           (39)     181     (133)     (108)
                                      ______   ______   ______    ______

Income/(loss) before income taxes        299      696     (319)     (343)

Income tax expense                        (1)      (5)      (5)       (8)
                                      ______   ______   ______    ______

Net income/(loss)                    $   298  $   691  $  (324)  $  (351)

  Net income/(loss) per share
    Basic                             $ 0.02   $ 0.05   $(0.02)  $ (0.03)
    Diluted                           $ 0.02   $ 0.05   $(0.02)  $ (0.03)
  Average number of shares Outstanding
    Basic                             13,162   13,162   13,162    13,162
                                      ======   ======   ======    ======
  Diluted                             13,162   13,162   13,162    13,162
                                      ======   ======   ======    ======

See Notes to Condensed Consolidated Financial Statements.

</TABLE>
                           3 of 14
                              
<PAGE>

<TABLE>

                 RHEOMETRIC SCIENTIFIC, INC.
       CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 (In thousands)           (Unaudited)

<CAPTION>
                                                  Six Months Ended
                                                       June 30,
                                                   1998       1997
                                                  _______   _______
<S>                                                <C>       <C>
Cash Flows from Operating Activities:
Net loss                                           $(324)   $ (351)

Adjustments to reconcile net loss to
 net cash (used in)/provided by
 operating activities:
  Depreciation and amortization of plant and
  Equipment                                          380       392
Amortization of goodwill and intangibles             121       134
Provision for inventory reserves                     416       336
Unrealized currency loss/(gain)                       99       (74)
 Loss on sale/retirement of plant and equipment        1        --
 Warrants issued                                      25        --
Changes in assets and liabilities:
 Accounts receivable                               3,550       551
 Inventories                                        (589)   (1,559)
 Prepaid expenses and other current
  Assets                                             (62)        5
 Accounts payable and accrued
  Liabilities                                     (2,419)     (862)
 Other assets                                        (27)       12
 Other non-current liabilities                        40        29
                                                  ______    ______

Net cash provided by/(used in)
 operating activities                              1,211    (1,387)
                                                   _____    ______
Cash Flows from Investing Activities:

 Purchases of property, plant, and equipment         (27)      (90)
                                                  ______    ______
Net cash used in investing activities                (27)      (90)
                                                  ______    ______

Cash Flows from Financing Activities:
Net (repayment)/borrowings under line
 of credit agreements                             (1,336)     (665)
Net (repayments)/borrowings against
 accounts receivables                                854     1,662
Repayment of long-term debt/lease obligation        (111)      (86)
Mortgage participation                                --       861
                                                  ______    ______
Net cash (used in)/provided by financing
 activities                                         (593)    1,772
                                                  ______    ______

Effect of exchange rate changes on cash              (57)      119
`                                                 ______    ______
Net increase in cash                                 534       414

Cash at beginning of period                          297       486
                                                  ______    ______
Cash at end of period                             $  831    $  900
                                                  ======    ======
Cash payments for interest                        $  809    $1,132
                                                  ======    ======
Cash payments for income taxes                    $  106    $   36
                                                  ======    ======

See Notes to Condensed Consolidated Financial Statements.

</TABLE>

                           4 of 14

<PAGE>


<TABLE>
        RHEOMETRIC SCIENTIFIC, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
            (In thousands, except per share data)
                         (Unaudited)
<CAPTION>

                                        Three Months      Six Months
                                        Ended June 30,   Ended June 30,
                                       1998     1997      1998      1997
                                      ______   ______    ______    ______

<S>                                   <C>     <C>       <C>       <C>
Net income/(loss)                      $ 298   $ 691     $(324)    $(351)
  Other comprehensive income
  Foreign currency translation
    Adjustments                          (35)    140       (89)      (87)
                                       _____   _____     _____     _____
    Other comprehensive income/(loss)    (35)    140       (89)      (87)
                                       _____   _____     _____     _____
    Comprehensive income/(loss)        $ 263   $ 831     $(413)    $(438)
                                       =====   =====     =====     =====

                              
</TABLE>
                 RHEOMETRIC SCIENTIFIC, INC.
                              
    NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. Accounting Policies

  The information included in the foregoing interim financial
   statements is unaudited. In the opinion of management, all
   adjustments, consisting of normal recurring accruals,
   necessary for a fair presentation of financial position and
   results of operations for the interim periods presented have
   been reflected herein.  The results of operations for the
   interim periods are not necessarily indicative of the results
   to be expected for the entire year.

   In June 1997, the Financial Accounting Standards Board
   (FASB) issued Statement of Financial Accounting Standards
   (SFAS) No. 131, "Disclosures about Segments of an
   Enterprise and Related Information," for fiscal years
   beginning after December 15, 1997. The provisions of SFAS
   No. 131 establish standards for the way that enterprises
   report information about operating segments in annual
   financial statements and require that selected
   information about operating segments in interim financial
   statements be reported.  It also establishes standards
   for related disclosure about products and services,
   geographic areas, and major customers.  The Company is
   reviewing these standards of disclosure for adoption in
   1998.

  Effective January 1, 1998, the Company adopted Statement
  of Financial Accounting Standards (SFAS) No. 130,
  "Reporting Comprehensive Income."  The provisions of SFAS
  No. 130 establish standards for reporting and display of
  comprehensive income and its components in the financial
  statements.  This
  
  
                           5 of 14

<PAGE>

  statement requires all items that are required to be
  recognized under accounting standards as components of
  comprehensive income be reported in the financial
  statements and displayed with the same prominence as other
  financial statements.
  
   In June 1998, the Financial Accounting Standards Board
   (FASB) issued Statement of Financial Accounting Standards
   (SFAS) No. 133, "Accounting for Derivative Instruments
   and Hedging Activities," for fiscal years beginning after
   June 15, 1999.  The provisions of SFAS No. 133 require
   all derivatives to be recognized in the statement of
   financial position as either assets or liabilities and
   measured at fair value.  In addition, all hedging
   relationships must be designated, reassessed and
   documented pursuant to the provisions of SFAS 133.  At
   present time the Company is reviewing the potential
   impact of this standard.
  
2.   Loss Per Share

  In February 1997, the Financial Accounting Standards Board
  issued Statement of Financial Accounting Standards No. 128,
  "Earnings Per Share" ("SFAS No. 128").  SFAS 128 establishes
  standards for computing and presenting earnings per share
  ("EPS") and supersedes APB Opinion No. 15.  "Earnings per
  Share" ("Opinion 15").  SFAS 128 replaces the presentation of
  primary EPS with a presentation of basic EPS which excludes
  dilution and is computed by dividing income available to
  common stockholders by the weighted-average number of common
  shares outstanding during the period.  Diluted reflects the
  potential dilution that could occur if outstanding options and
  warrants were exercised. This statement has no effect on the
  Company's prior period EPS data.
  
  
3.   Long-term Debt and Short-term Borrowings

   Long-term debt consists of the following:
                                      
                                   June 30, 1998  December 31, 1997
                                   _____________   _____________    
   Obligation under sale/leaseback
     payable through February 2011,
     with interest imputed at a
     weighted-average rate of
     13.9% for 1998 and 1997,
     respectively                    $4,879,000     $4,857,000
   
   Note payable through November
      1999 with interest at 9.54%       125,000        167,000
                                     __________     __________ 
                                      5,004,000      5,024,000
   Less current maturities              229,000        227,000
                                     __________     __________ 
                                     $4,775,000     $4,797,000
                                     ==========     ==========
   
   
                           6 of 14

<PAGE>

   The Company has working capital lines of credit with
   certain domestic and foreign banks.  The foreign working
   capital lines of credit are supported by letters of
   credit issued under the Company's Loan and Security
   Agreement, as amended, (the "Loan Agreement").  Total
   borrowings were $7,313,000 with remaining availability of
   approximately $3,242,000 at June 30, 1998. Interest on
   the domestic line of credit at June 30, 1998 was 10% and
   10% at December 31, 1997.  Interest rates on the foreign
   lines of credit ranged between 1.9% and 8.5% as of June
   30, 1998 and between 1.9% and 6.8% at December 31, 1997.
   
   The Loan Agreement requires the Company to maintain a
   minimum tangible net worth and working capital, generate
   minimum consolidated and domestic cash flows, and
   achieve a minimum adjusted funded debt to adjusted
   tangible net worth ratio.  In addition, the Loan
   Agreement prohibits the payment of cash dividends or cash
   distributions to shareholders.
   
   During 1997 and the first half of 1998, the Company had
   been in violation of certain debt covenants associated
   with its obligation under a sale/leaseback arrangement
   and its short-term loan agreement.  The Company has
   obtained waivers covering these violations and believes
   that they will be in compliance with applicable debt
   covenants for periods subsequent to June 30, 1998.
   Financial covenants under the sale/leaseback arrangement
   have been waived through December 31, 1998.
   
   The Company's lines and letters of credit are subject to
   acceleration in the event that there is a material and
   adverse change in the condition or affairs, financial or
   otherwise, of the Company which in the reasonable opinion
   of the lender impairs the lender's collateral or
   increases its risk so as to jeopardize the repayment of
   the obligations.
   
   The Loan Agreement expires on February 23, 1999, and the
   lender notified the Company in August 1998 that the Loan
   Agreement will not be extended beyond the expiration
   date.  Following that notification, the Company has
   commenced discussions with other prospective lenders to
   replace the credit facility provided by the Loan
   Agreement with a credit facility with a maximum available
   credit of $10,000,000.  The ability to proceed with a
   lesser maximum credit than available under the current
   Loan Agreement is based on existing improvements in the
   management of the Company's working capital.  While the
   Company believes it will be able to secure a new credit
   facility on or prior to the expiration date of the Loan
   Agreement, it has not yet received a commitment for such
   a facility and there can be no assurance that it will do
   so.
   
                           7 of 14

<PAGE>

4.   1997 Restructuring
   
   During the third quarter 1997, the Company undertook
   several strategic initiatives designed to improve
   operational efficiencies and cash management, as well as
   to enhance its market position and customer support.
   These initiatives included a restructuring of
   manufacturing operations, a restructuring of
   international sales and marketing activities, and an
   introduction of new products targeted to broaden markets
   for rheology and process control instrumentation.  The
   restructuring and consolidation efforts resulted in a one-
   time write-off of $2,224,000, $600,000 related to
   inventory obsolescence and a restructuring charge of
   $1,624,000.  These charges are reflected in the Company's
   third quarter 1997 financial results. At December 31,
   1997 the restructuring reserve of $1,624,000 was reduced
   by $684,000 as the result of the assignment of the UK
   lease to a third party at more favorable terms than
   initially anticipated.  The restructuring reserve of
   $733,000 as of June 30, 1998 is a component of accrued
   liabilities in the Consolidated Balance Sheet.
   Approximately $157,000 was charged to the restructuring
   reserve in the second quarter, while $207,000 was charged
   during the six months ended June 30, 1998.
   
   The Company's restructuring plan centers on its European
   operations.  The Company will change the focus of Europe
   to be centralized in Germany, while maintaining a strong
   presence in both the U.K. and France.  It expects this
   plan to be in full effect in the second half of 1998.


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF
OPERATIONS AND FINANCIAL CONDITION
                              
Results of Operations

Sales for the three- and six-month period ended June 30,
1998 decreased $1,688,000 and $3,211,000 (or 16.2% and
17.2%), respectively, as compared to the corresponding
periods in 1997.  These figures include a negative impact of
$289,000 and $475,000 on sales for the three and six months
ended June 30, 1998 due to unfavorable currency rates in
effect.  The decline in revenue for the six month period
resulted from a decrease in Europe and Japan of $2,215,000
and $1,506,000, respectively, offset by an increase of
$510,000 in the Americas.  The decline in revenue for the
three-month period represents a decrease in Europe and Japan
of $838,000 and $1,128,000, respectively, offset by an
increase in the Americas of $278,000.  For the six-month
period, total international sales of $7,414,000 represented
47.8% of total sales compared to 1997 international sales of
$11,135,000, which amounted to 59.5% of total sales.  The
gross profit percentages for the three and six months ended
June 30, 1998 were 48.5% and

                           8 of 14

<PAGE>
                              
48.4%, respectively.  This compares to 48.8% and 46.1% for
the same periods in the prior year.

Operating expenses for the three and six months ended June
30, 1998 were down $720,000 and $1,228,000 compared to the
corresponding periods in the prior year.  For both the three-
and six-month periods, operating expenses were favorably
affected by foreign currency trends of $69,000 and $137,000,
respectively. The remaining decline is due to cost reduction
measures that the Company had taken in the third quarter
1997 and second quarter 1998.

Net interest expense for the three and six months ended June
30, 1998 increased $50,000 and $49,000, respectively,
compared to the corresponding periods in the prior year.

The Company is exposed to foreign currency gains and losses
related to its intercompany payables and another payable to
Mettler Toledo AG, pursuant to the exclusive world-wide
property rights agreement between the Company and Mettler,
which is due in Swiss Francs.  The Company's foreign
currency exposure policy is to not enter into foreign
currency derivative instruments.

The foreign currency adjustments for the three and six
months ended June 30, 1998 were a loss of $39,000 and
$133,000, respectively.  The year-to-date adjustment was
primarily due to transaction losses of $187,000 resulting
from the French Franc, Japanese Yen, and Swiss Franc which
were offset by gains of $54,000 related to the German Mark
and British Pound.

Inherent in the Company's business is the potential for
inventory obsolescence for older products as the Company
develops new products.  Obsolescence has historically related
to parts inventory.  The Company continuously monitors its
exposure relating to excess and obsolete inventory and
establishes what in management's judgment at the time are
appropriate valuation reserves.

Liquidity and Capital Resources

Management believes that cash generated from operations and
funds available under lines of credit should be sufficient
to meet the Company's working capital needs until February
23, 1999, and thereafter depending on the Company's success
in obtaining a new credit facility. Adequacy of cash flows
beyond that period will depend upon the Company's ability to
achieve expected sales volumes to support profitable
operations.

The Company has working capital lines of credit with certain
domestic and foreign banks.  The foreign working capital
lines of credit are supported by letters of credit issued
under the Company's Loan and Security Agreement, as amended,
(the "Loan Agreement").  Total borrowings were $7,313,000
with remaining

                           9 of 14
                              
<PAGE>


availability of approximately $3,242,000 at June 30, 1998.
Interest on the domestic line of credit at June 30, 1998 was
10% and 10% at December 31, 1997.  Interest rates on the
foreign lines of credit ranged between 1.9% and 8.5% as of
June 30, 1998 and between 1.9% and 6.8% at December 31,
1997.
   
The Loan Agreement expires on February 23, 1999, and the lender
notified the Company in August 1998 that the Loan Agreement
will not be extended beyond the expiration date.  Following
that notification, the Company has commenced discussions with
other prospective lenders to replace the credit facility
provided by the Loan Agreement with a credit facility with a
maximum available credit of $10,000,000.  The ability to
proceed with a lesser maximum credit than available under the
current Loan Agreement is based on existing improvements in the
management of the Company's working capital.  While the Company
believes it will be able to secure a new credit facility on or
prior to the expiration date of the Loan Agreement, it has not
yet received a commitment for such a facility and there can be
no assurance that it will do so.

Cash Flows from Operations. Net cash provided by operating
activities during the six months ended June 30, 1998 was
$1,211,000, an increase of $2,598,000 over the same period
last year.  Net loss for the six months ended June 30, 1998
was $324,000 compared to $351,000 during the same period
last year. During the six months ended June 30, 1998,
accounts receivable
decreased by $3,550,000 reflecting lower second quarter 1998
sales as compared to the last quarter 1997 sales.
Inventories increased by $589,000 partially due to lower
than anticipated 1998 sales.  Management continuously
monitors inventory levels on a worldwide basis in order to
ensure that excess inventory is kept to a minimum. Accounts
payable and accrued liabilities decreased $2,419,000.

Cash Flows From Investing.  Net cash used in investing
activities during the six months ended June 30, 1998 was
$27,000 as compared to $90,000 during the same period in
1997.

Cash Flows From Financing.  Net cash used in financing
activities during the six-month period ended June 30, 1998
was $593,000.
The Company's borrowing against its accounts receivable
during the six-month period ended June 30, 1998 increased
$854,000 while its borrowing under line of credit agreements
decreased $1,336,000.

Year 2000 Compliance.  The Company has consulted with its
main software provider regarding potential year 2000
problems.  The majority of this potential problem has been
addressed and the remaining problem area will be addressed
via upgrades, which will be available prior to the year
2000. In addition, the Company has proactively identified
program modifications that may require a change in
programming code.  Such code modifications are being

                          10 of 14

<PAGE>


actively made and the Company anticipates that all program
modifications will be completed well before the year 2000.
The Company plans to initiate in 1998 communication with its
significant suppliers to determine the effect that it may be
impacted by third parties failure to address this issue.
The Company will continue to monitor and evaluate the impact
of year 2000 on its operations.
                              
                 PART II.  OTHER INFORMATION

Item 2.   Changes in Securities

     A Consulting Services Agreement was entered into
     effective April 1, 1998 in which the Company agreed to
     compensate a consultant for investment advisory and
     investment banking services with warrants to purchase
     shares of common stock of the Company at $1.65 per
     share for a period of five years.  The Consulting
     Services Agreement was terminated by the Company
     effective August 19, 1998.  Under the terms of the
     agreement, the consultant earned warrants to purchase
     326,667 shares prior to termination of the agreement.
     These warrants were issued pursuant to Section 4(2) of
     the Securities Act of 1933.
     
Item 5.    Other Information

     The Company's common stock was moved to the OTC-
     Bulletin Board Market, effective with the close of
     trading on April 14, 1998, due to the expiration of an
     exception from the minimum bid price of the NASDAQ
     SmallCap Market.
     
     In August 1998 the Company assigned the lease of its
     Epsom facility in the United Kingdom to a third party
     and moved its sales and service personnel to offices
     located in Leatherhead.

Item 6.   Exhibits and Reports on Form 8-K

      (a)Exhibits (numbered in accordance with Item 601 of
          Regulation S-K).

      3.1  Certificate of Incorporation of the Registrant,
           as Amended, incorporated by reference to Exhibit
           3.1 to the Company's Quarterly Report on Form 10-
           Q for the period ended March 31, 1995 (File No.
           0-14617).
      3.2  By-Laws of the Registrant, as Amended,
           incorporated by reference to Exhibit 3.2 to the
           Company's Annual Report on Form 10-K for the
           year ended December 31, 1993 (File No. 0-14617).
      
                          11 of 14
                              
<PAGE>

Item 6. - continued

      4.1  Specimen Certificate representing Common Stock
           of the Registrant, incorporated by reference to
           the exhibits to the Company's Registration
           Statement on Form S-1, File No. 33-807 filed on
           October 10, 1985.
      4.2  Warrant to Purchase 132,617 shares Common Stock of
           Rheometric Scientific, Inc. issued to RSI (NJ) QRS 12-13,
           Inc., incorporated by reference to Exhibit 1 to the
           Company's Current Report on Form 8-K dated February 23, 1996
           (File No. 0-14617).
      4.3  Warrant to Purchase 331,543 shares of Common Stock of
           Rheometric Scientific, Inc. issued to RSI (NJ) QRS 12-13,
           Inc., incorporated by reference to Exhibit 2 to the
           Company's Current Report on Form 8-K dated February 23, 1996
           (File No. 0-14617).
     *4.4  Rheometric Scientific, Inc. 1996 Stock
           Option Plan, incorporated by reference to
           Exhibit 4.3 to the Company's Quarterly Report on
           Form 10-Q for the period ended June 30, 1996
           (File No. 0-14617).
     *10.1 Amended and Restated Employment Agreement
           between Ronald F. Garritano and the Company
           incorporated by reference to Exhibit 10.3 to the
           Company's Annual Report on Form 10-K dated
           December 31, 1997 (File No. 0-14617).
     *10.2 Employment Agreement between Matthew Bilt
           and the Company, incorporated by reference to
           Exhibit 10.4 to the Company's Quarterly Report
           on Form 10-Q for the period ended September 30,
           1996 (File No. 0-14617).
     *10.3 Employment Agreement between Joseph Musanti and
           the Company incorporated by reference to Exhibit
           10.4 to the Company's Annual Report on Form 10-K
           dated December 31, 1997 (File No. 0-14617).
     10.4  Loan and Security Agreement with Fleet Capital
           Corporation dated February 23, 1996,
           incorporated by reference to Exhibit 1 to the
           Company's Current Report on Form 8-K dated
           February 23, 1996 (File No. 0-14617).
     10.5  Lease Agreement by and between RSI (NJ) QRS 12-
           13, Inc., and Rheometric Scientific, Inc. dated as of
           February 23, 1996, incorporated by reference to Exhibit 5 to
           the Company's Current Report on Form 8-K dated February 23,
           1996 (File No. 0-14617).
     10.6  Revolving Credit Facility Note - Fleet Capital
           Corporation, incorporated by reference to Exhibit 6 to the
           Company's Current Report on Form 8-K dated February 23, 1996
           (File No. 0-14617).
     10.7  Subordination Agreement between Axess
           Corporation and Fleet Capital Corporation, incorporated by
           reference to Exhibit 10.26 to the Company's Annual Report on
           Form 10-K dated December 31, 1995 (File No. 0-14617).

                          12 of 14

<PAGE>

Item 6 - continued

     10.8  Subordination Agreement between Axess
           Corporation and RSI (NJ) QRS 12-13, Inc., incorporated by
           reference to Exhibit 10.27 to the Company's Annual Report on
           Form 10-K dated December 31, 1995 (File No. 0-14617).
     10.9  Amended and Restated Subordinated Unsecured
           Working Capital Note - Axess Corporation, incorporated by
           reference to Exhibit 10.28 to the Company's Annual Report on
           Form 10-K dated December 31, 1995 (File No. 0-14617).
     10.10 First Amendment to Lease Agreement dated June 10,
           1996 between RSI (NJ) QRS 12-13, Inc. and Rheometric
           Scientific, Inc. incorporated by reference to Exhibit 10.12
           to the Company's Annual Report on Form 10-K dated December
           31, 1996 (File No. 0-14617).
     10.11 Second Amendment to Lease Agreement dated February
           20, 1997 between RSI (NJ) QRS 12-13, Inc. and Rheometric
           Scientific, Inc. incorporated by reference to Exhibit 10.13
           to the Company's Annual Report on Form 10-K dated December
           31, 1996 (File No. 0-14617).
     10.12 Amendment Letter dated May 2, 1997 by Fleet
           Capital Corporation, amending Sections 9.1(J) and 9.3(D) of
           the Loan and Security Agreement dated February 23, 1996,
           incorporated by reference to Exhibit 10.14 to the Company's
           Annual Report on Form 10-K dated December 31, 1996 (File No.
           0-14617).
     10.13 Amendment Letter dated May 6, 1997 by RSI (NJ) QRS-
           12-13, Inc., amending paragraphs 7 and 8 of Exhibit D to the
           Lease Agreement dated as of February 23, 1996, incorporated
           by reference to Exhibit 10.15 to the Company's Annual Report
           on Form 10-K dated December 31, 1996 (File No. 0-14617).
     10.14 Amendment to Loan and Security Agreement with
           Fleet Capital Corporation dated March 31, 1998 incorporated
           by reference to Exhibit 10.16 to the Company's Annual Report
           on Form 10-K dated December 31, 1997 (File No. 0-14617).
     24    Consent of Independent Auditors incorporated by
           reference to Exhibit 22 to the Company's Annual
           Report on Form 10-K dated December 31, 1997
           (File No. 0-14617).
     27    Financial Data Schedule


(b)       Reports on Form 8-K:

               None.
                              
                          13 of 14

<PAGE>

                              
                              
                         SIGNATURES
                              
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly
authorized.

                            RHEOMETRIC SCIENTIFIC, INC.
                            (Registrant)




October 2, 1998             By     /s/ Joseph Musanti
                             Joseph Musanti, Vice President,
                              Finance & Materials and
                              Chief Financial Officer


                          14 of 14
                              
<PAGE>



<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000779164
<NAME> RHEOMETRIC SCIENTIFIC
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                             831
<SECURITIES>                                         0
<RECEIVABLES>                                   11,054
<ALLOWANCES>                                         0
<INVENTORY>                                     11,981
<CURRENT-ASSETS>                                24,738
<PP&E>                                          15,974
<DEPRECIATION>                                   9,815
<TOTAL-ASSETS>                                  31,908
<CURRENT-LIABILITIES>                           17,146
<BONDS>                                          4,775
                                0
                                          0
<COMMON>                                            13
<OTHER-SE>                                       2,429
<TOTAL-LIABILITY-AND-EQUITY>                    31,908
<SALES>                                         15,497
<TOTAL-REVENUES>                                15,497
<CGS>                                            7,997
<TOTAL-COSTS>                                    7,997
<OTHER-EXPENSES>                                 6,485
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,201
<INCOME-PRETAX>                                  (319)
<INCOME-TAX>                                       (5)
<INCOME-CONTINUING>                              (324)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (324)
<EPS-PRIMARY>                                   (0.02)
<EPS-DILUTED>                                   (0.02)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission